A Study of Tasisulam-sodium Versus Paclitaxel as Treatment for Metastatic Melanoma

NCT01006252 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

336

Enrollment

INDUSTRY

Sponsor class

Stopped More possibly treatment-related deaths on tasisulam-sodium arm.

Conditions

Melanoma

Interventions

DRUG: Tasisulam-sodium
DRUG: Paclitaxel

Sponsor

Eli Lilly and Company